Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New whole blood test for toxoplasmosis
Toxoplasma gondii can be found in the faeces of infected cats.
Test could improve maternal-child health outcomes

A new low-cost whole blood test for toxoplasmosis has been developed by researchers at the University of Chicago.

In the study, researchers tested 205 people known to be infected with toxoplasmosis, including pregnant women. The blood was tested using reference tests, standard serum tests and the new whole-blood point of care (POC), obtained by finger stick.

They found that the whole blood test had a 100 per cent agreement with conventional testing and proved highly sensitive (100 per cent) and specific (100 per cent).  The scores also held true for women with lower levels of anti-Toxoplasma antibodies.

"Our work establishes a new point of care test in the outpatient setting at very low cost enabling diagnosis and prompt treatment for toxoplasma infections acquired for the first time during pregnancy,” the authors note.  

“This enables life, sight and cognition saving treatments. If combined with multiplexed testing for other congenital infections and markers associated with premature birth, it will markedly improve maternal-child outcomes and save lives."

Toxoplasmosis is a disease caused by the parasite Toxoplasma gondii. The parasite can be found in undercooked contaminated meat or in the faeces of infected cats.

Transmission of toxoplasmosis from a mother to her unborn child can result in severe congenital problems and fetal death. As such, testing for the parasitic infection during pregnancy is critical.

Current tests for toxoplasmosis are serum tests, which require blood samples to be processed using infrastructure and technology. This can be prohibitive, however, in developing countries and unaffordable in developed countries like the United States.

The study, Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies, is published in PLOS Neglected Tropical Diseases.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.